Loading…
The DJ-1 protein as a candidate biomarker in obstructive sleep apnea syndrome
Background Oxidative stress has a central role in the pathophysiology of obstructive sleep apnea syndrome (OSAS). The DJ-1 protein functions as a sensor of oxidative stress, acting both as a reactive oxygen species scavenger (ROS) and an antioxidative response regulator. The aim of our study is to d...
Saved in:
Published in: | Sleep & breathing 2014-12, Vol.18 (4), p.897-900 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Oxidative stress has a central role in the pathophysiology of obstructive sleep apnea syndrome (OSAS). The DJ-1 protein functions as a sensor of oxidative stress, acting both as a reactive oxygen species scavenger (ROS) and an antioxidative response regulator. The aim of our study is to determine the serum levels of DJ-1 in OSAS patients and assess possible correlations with their clinical, demographical, and biochemical characteristics.
Methods
The study included 120 subjects from the Sleep Disorder Laboratory of the University Hospital of Thessaly (100 males vs 20 females, mean age 48 ± 10, Apnea–Hypopnea Index (AHI) >5 episodes per hour of sleep). Subjects underwent full-night polysomnography (PSG) followed by morning blood sampling. Serum DJ-1 levels were determined via ELISA kits. Statistical analysis was performed using SPSS 19.
Results
The median DJ-1 levels were 56.7 ng/mL (IQR, 34.9–99.3 ng/mL). Statistically significant correlations were detected between DJ-1’s levels and AHI (Spearman’s rho = 0.189,
P
= 0.04), Desaturation Index (DI; Spearman’s rho = 0.239,
P
= 0.012), and serum low-density lipoprotein (LDL) (Spearman’s rho = −0.205,
P
= 0.042).
Conclusions
DJ-1 may be a useful biomarker in OSAS due to its correlations with AHI and DI. The correlation with serum LDL warrants further investigation regarding possible implications in OSAS patients’ cardiovascular comorbidities. |
---|---|
ISSN: | 1520-9512 1522-1709 |
DOI: | 10.1007/s11325-014-0952-6 |